Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Income towards Parent Company (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Income towards Parent Company for 16 consecutive years, with -$82.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 2109.67% year-over-year to -$82.9 million, compared with a TTM value of -$94.9 million through Dec 2025, down 551.64%, and an annual FY2025 reading of -$94.9 million, down 551.64% over the prior year.
  • Income towards Parent Company was -$82.9 million for Q4 2025 at Cross Country Healthcare, down from -$4.8 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $77.6 million in Q4 2021 and bottomed at -$82.9 million in Q4 2025.
  • Average Income towards Parent Company over 5 years is $14.0 million, with a median of $11.9 million recorded in 2021.
  • The sharpest move saw Income towards Parent Company skyrocketed 1709.07% in 2021, then tumbled 2109.67% in 2025.
  • Year by year, Income towards Parent Company stood at $77.6 million in 2021, then tumbled by 53.19% to $36.3 million in 2022, then crashed by 75.11% to $9.0 million in 2023, then plummeted by 141.52% to -$3.8 million in 2024, then crashed by 2109.67% to -$82.9 million in 2025.
  • Business Quant data shows Income towards Parent Company for CCRN at -$82.9 million in Q4 2025, -$4.8 million in Q3 2025, and -$6.7 million in Q2 2025.